Login or register to see your saved jobs and receive scout emails
Login or register to find a job

U-Medico Inc.

Company Description

U-Medico offers cutting-edge analytical services to bring the quality of biopharmaceuticals to the world's highest level.

U-Medico Inc., a spin-out from Osaka University, is an analytical and research service provider of biopharmaceuticals and new modalities. We provide high-quality analytical and formulation development services for biopharmaceuticals, including antibodies and fusion proteins, as well as gene therapeutics, to more than 40 domestic and international clients annually. We provide comprehensive support to our clients from the drug discovery stage through drug development, submission, and post-approval, contributing to safe and reliable drug development.

Our strength is our world-leading analytical technology, extensive experience, and unique know-how in utilizing that technology. In particular, we have a strong background in unique and highly accurate biophysical characterization, including analytical ultracentrifugation (AUC), hydrogen/deuterium exchange mass spectrometry (HDX-MS), and particles and aggregates analysis. We have helped our clients solve problems in pharmaceutical development.

In formulation development services, we entered into a strategic partnership with Coriolis Pharma, a world-leading company in formulation research and development, to further improve our technologies. Technical collaboration is being promoted to realize innovative formulation development services.


Furthermore, in April 2022, U-Medico launched its Cell and Gene Therapy Unit to take responsibility for the future of pharmaceuticals. In recent years, gene therapy, in which therapeutic genes are introduced into the body to treat genetic diseases fundamentally, has been gaining attention. The unit will provide intensively world-class analytical and quality testing services to ensure the stable production of high-quality cell and gene therapies.

We listen sincerely to our clients' concerns and propose solutions and new opportunities. As an analytical expert, researcher, and consultant, we will accompany you on your drug development journey. We hope you will use our knowledge and experience in your business.

Company Details

Head Office
Japan  
Main Business
分析・研究サービス  
President
福原 彩乃 / Ayano Fukuhara, Ph.D.  
Established
2006年  
Capital
3,000万円 
URL
https://u-medico.co.jp/  

Offices

Main Office
502 Photonics Center, Osaka University
2-1 Yamadaoka, Suita-shi
Osaka, Japan, 5650871

New Jobs